Form 4: Praxis Precision Medicines CEO Acquires Shares Through Employee Stock Purchase Plan
SEC Form 4 Filing
Praxis Precision Medicines CEO Marcio Souza acquired 1,718 shares of common stock through the company's Employee Stock Purchase Plan at a price of $12.368 per share.
Summary
- On May 14, 2024, Marcio Souza, CEO of Praxis Precision Medicines, Inc., acquired 1,718 shares of common stock.
- The shares were purchased through the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan at a price of $12.368 per share.
- Following the transaction, Souza directly owns 16,894 shares of common stock.
- Souza also indirectly owns 3,000 shares held by his spouse.
Sentiment
Score: 6
Explanation: Neutral sentiment as it reflects a routine transaction. The CEO's participation in the employee stock purchase plan is a positive signal, but it's not a major event.
Positives
- The CEO's participation in the Employee Stock Purchase Plan demonstrates confidence in the company's future.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's alignment with shareholder interests.
Key Dates
| Date | Description |
|---|---|
| 05/14/2024 | Date of transaction: CEO acquired shares through the Employee Stock Purchase Plan |
| 05/20/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.